Research Report
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4377-4381
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4377
Figure 2
Figure 2 Risk of additional malignancy. A: Primary was lymphoproliferative (33%) vs solid tumor (15.5%), P < 0.01; B: Primary endoscopic modality was gastroscopy (25.6%) vs colonoscopy (17.2%), P = 0.12.